SFS
MIST icon

Sowell Financial Services’s Milestone Pharmaceuticals MIST Stock Holding History

Sowell Financial Services’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,440
Closed -$8K – 1860
2021
Q1 		$8K Buy
+1,440
New +$10.5K ﹤0.01% 2408
2020
Q3 		– Sell
-8,000
Closed -$30K – 2644
2020
Q2 		$30K Buy
+8,000
New +$25.8K ﹤0.01% 1335

Other funds holding MIST

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Sowell Financial Services's MIST Position: Q2 2021 in Review

Sowell Financial Services sold out of Milestone Pharmaceuticals (MIST) in Q2 2021, closing a stake of 1,440 shares — an estimated $8K sold.

Sowell Financial Services first reported a position in MIST in Q2 2020 and held it in 2 quarters. The position peaked at $30K in Q2 2020. 28 funds tracked by Wall St. Rank hold MIST as of Q2 2021.

  • Sowell Financial Services reported no remaining Milestone Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,440 Milestone Pharmaceuticals shares in Q2 2021, an estimated $8K.
  • Sowell Financial Services first reported a position in Milestone Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Sowell Financial Services's Milestone Pharmaceuticals position peaked at $30K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.